CALGENE REPORTS DEEPER NET LOSSCalgene Inc. (NASDAQ:CGNE) of Davis, Calif., said a reduction inrevenues and an increased loss for the first six monthscompared with the previous year is due primarily to a $2.5million sale of technology rights in non-core crop areas.Research and development expenditures for the first sixmonths reflect a decrease of 14 percent from the prior year's$6.2 million. The reduction in R&D expenses reflects therestructuring and focus on the core crop areas implemented bythe company in June 1990, the company said.

Second quarter ended Dec. 31.

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues $5,290 6,754 -22Net income (loss) (3,874) (1,761) -120Net income per share (loss) (.42) (.23) -83Outstanding shares 10,746 10,417 +3

XYTRONYX REPORTS HIGHER REVENUES, DEEPER LOSS

Xytronyx Inc. (AMEX:XYX) of San Diego.

Third quarter ended Dec. 31.

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues $97 $47 +106Net income (loss) (645) (319) -102Net income per share (loss) (.20) (.13) -54Outstanding shares 3,221 2,494 +29

NICHOLS REPORTS INCREASED REVENUES

Dr. Albert L. Nichols, chairman of the board and chief executiveofficer, of Nichols Institute (ASE:LAB) of San Juan Capistrano,Calif., said the company's reported results are in line with itsexpectations for 1990. He said the results reflect continuedsteady growth in the company's core Reference Laboratoryoperations, its Midwest-based regional laboratories and itsdiagnostic kit business. He also said that fourth-quarter resultswere adversely affected by the company's new operations atits regional laboratory in Portland, Ore., and its joint-venturelaboratory in Dallas.

Fourth quarter ended Dec. 31.

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues $45,481 34,220 +33Net income (loss) 1,261 1,373 -8Net income per share (loss) .09 .11 -18Outstanding shares 14,811 12,330 +20

Fiscal year ended Dec. 31.

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues $174,801 129,708 +35Net income (loss) 6,881 4,774 +44Net income per share (loss) .49 .43 +14Outstanding shares 13,968 11,134 +25

(c) 1997 American Health Consultants. All rights reserved.

No Comments